MT1DP and central nervous system cancer: Our current studies showed that MTM expression was obviously up-regulated in glioma cells after WZY-321 treatment, further overexpression of MTM markedly down-regulated the expression of miR-873, suggesting that MTM may cause miR-873 degradation through binding to miR-873.